Lansforsakringar Fondforvaltning Ab (Publ) Sarepta Therapeutics, Inc. Call Options Transaction History
Lansforsakringar Fondforvaltning Ab (Publ)
- $18.8 Billion
- Q3 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding SRPT
# of Institutions
440Shares Held
83.3MCall Options Held
5.59MPut Options Held
4.18M-
Vanguard Group Inc Valley Forge, PA10.8MShares$194 Million0.0% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$186 Million0.04% of portfolio
-
State Street Corp Boston, MA4.7MShares$84.4 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY4.48MShares$80.5 Million0.06% of portfolio
-
Erste Asset Management Gmb H Vienna, C42.69MShares$48.3 Million0.49% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $1.57B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...